CanPrev K2 Drops - K2VITAL MK-7 Liquid Vitamin K2 | 15mL
Visit the CanPrev Store Read all reviews on Amazon →| Brand | CanPrev |
| Serving | 4 drops (adults 19+) |
| Licensed Natural Health Product | NPN 80082329 |
| Quality Standards | Made in Canada |
| Country | Made in Canada  |
About this item
- SUPPORTS STRONG BONES: 30mcg of bioactive vitamin K2 (menaquinone-7, K2VITAL®) in every drop, helping guide calcium to where it's needed for bone health - in a tasteless, fast-absorbing liquid format.
- EFFORTLESS DAILY ROUTINE: An unflavored liquid that blends easily into a smoothie, a glass of water, or a favourite meal - no pills or capsules to swallow.
- BIOACTIVE K2VITAL® MK-7: A 100% all-trans form of menaquinone-7, sourced from non-soy plant oils (geraniol and farnesol), recognized for a long half-life and strong bioavailability among vitamin K forms.
- PRECISE, CONVENIENT DOSING: Each 15ml bottle delivers approximately 450 drops - roughly a 112-day supply at the adult dose of 4 drops daily, dispensed with an easy-to-use dropper.
- MCT OIL BASE FOR ABSORPTION: Vitamin K2 is a fat-soluble nutrient that relies on a lipid carrier for absorption - this formula uses medium chain triglycerides rather than a water or powder base.
Product Description
K2 Drops - K2VITAL® MK-7 Liquid - 30mcg Bioactive Vitamin K2 Per Drop
30mcg of bioactive vitamin K2 (menaquinone-7, K2VITAL®) in every tasteless drop - suspended in a medium chain triglyceride oil base designed to support absorption of this fat-soluble nutrient. The recommended adult dose of 4 drops daily provides 120mcg of K2. Licensed Natural Health Product. NPN 80082329. Licensed Natural Health Product NPN 80082329.
30 mcg de vitamine K2 bioactive (ménaquinone-7, K2VITAL®) dans chaque goutte sans saveur - en suspension dans une base d'huile de triglycérides à chaîne moyenne conçue pour favoriser l'absorption de ce nutriment liposoluble. La dose quotidienne recommandée de 4 gouttes fournit 120 mcg de K2. Produit de santé naturel homologué. NPN 80082329.
One Drop, Bioactive Vitamin K2
30mcg K2 (K2VITAL® MK-7) per Drop - Vegan, Gluten-Free, Made in Canada
Bioactive K2VITAL® Menaquinone-7
A 100% all-trans, highly bioactive form of vitamin K2 (MK-7) sourced from non-soy plant oils - the form of vitamin K recognized for a long half-life and strong bioavailability among vitamin K forms.
Suspended in an MCT Oil Base
Vitamin K2 is a fat-soluble vitamin that relies on a lipid carrier for absorption - this formula uses medium chain triglycerides rather than a water or powder base.
Advanced Ingredients, Superior Results
A single, bioactive nutrient working to support bone health - here is what's inside every drop of CanPrev K2 Drops.
Vitamin K2 (menaquinone-7, K2VITAL®)
A highly bioactive, all-trans form of vitamin K2, sourced from non-soy plant oils, that helps guide calcium toward bone and away from arteries.
30 mcg per drop
CanPrev K2 Drops: Supplement Facts
Supplement Facts
- Vitamin K2 (menaquinone-7, K2VITAL®) per drop (0.033 mL)30 mcg
Non-Medicinal Ingredients: Non-medicinal ingredients: Medium chain triglycerides (from coconut), D-alpha tocopherol.
Recommended Use or Purpose: Helps in the maintenance of bones.
Recommended Dose: Adults (19 years and older): take 4 drops per day (120 mcg of vitamin K2), or as directed by a health care practitioner. Shake well before use.
Cautions and Warnings: Ask a health care practitioner prior to use if you are taking blood thinners. Keep out of reach of children. Do not use if the safety seal is broken.
Actual product packaging and materials may contain more and different information than shown on our website. Always read labels, warnings and directions before using or consuming a product. This item is sold and shipped by Amazon.ca; purchases are completed on Amazon.
Fiche produit
- Vitamine K2 (ménaquinone-7, K2VITAL®) par goutte (0,033 mL)30 mcg
Ingrédients non médicinaux : Ingrédients non médicinaux : Triglycérides à chaîne moyenne (de noix de coco), D-alpha tocophérol.
Usage ou fins recommandés : Aide au maintien des os.
Posologie recommandée : Adultes (19 ans et plus) : prendre 4 gouttes par jour (120 mcg de vitamine K2), ou selon les directives d'un professionnel de la santé. Bien agiter avant usage.
Mises en garde : Consulter un professionnel de la santé avant l'usage si vous prenez des anticoagulants. Garder hors de la portée des enfants. Ne pas utiliser si le sceau de sécurité est brisé.
NPN 80082329
Support strong bones with bioactive K2VITAL MK-7 vitamin K2
Get CanPrev K2 Drops on Amazon.ca - fast, protected delivery.
Get it on Amazon.caWhy CanPrev K2 Drops
30mcg of bioactive K2VITAL® MK-7 vitamin K2 per drop in an MCT oil base - premium CanPrev quality.
Bioactive K2VITAL® menaquinone-7
A 100% all-trans, highly bioactive form of MK-7 sourced from non-soy plant oils, recognized for a long plasma half-life and strong bioavailability among vitamin K forms.
MCT oil base, not water or powder
Vitamin K2 is fat-soluble - this formula suspends it in a medium chain triglyceride oil base to support absorption.
Precise liquid dosing
Each drop is easy to measure, with approximately 450 drops per 15ml bottle - about a 112-day supply at the adult dose of 4 drops daily.
Vegan, gluten-free, made in Canada
A vegan, gluten-free, soy-free formula, free from sugar and artificial colours or flavours - a licensed Natural Health Product made in Canada. NPN 80082329.
Inside every drop
30mcg of vitamin K2 (menaquinone-7, K2VITAL®) in a tasteless, fast-absorbing MCT oil base - the recommended adult dose of 4 drops provides 120mcg of K2 per day.
How to use it
Shake well before use
Shake the bottle well, then dispense drops directly into the mouth using the dropper, or add to a smoothie, water, or food.
Take 4 drops daily
Adults (19 years and older): take 4 drops per day, or as directed by a health care practitioner.
Take consistently, at the same time each day
For steady daily vitamin K2 intake, take your dose at a consistent time each day.
Ask a health care practitioner if taking blood thinners
Consult a health care practitioner prior to use if you are taking blood thinners, or if you have any other health condition.
What the research says about vitamin K2 (menaquinone-7)
Educational summaries of published research on vitamin K2 (menaquinone-7, MK-7); not product-specific claims. CanPrev K2 Drops' claim is the authorized use under NPN 80082329.
Human trial: MK-7 absorbs steadily with a long plasma half-life and no daily rhythm
Randomized single-dose pharmacokinetic trials in healthy adults found MK-7 reached peak plasma concentration about 6 hours after intake with a very long half-life, and demonstrated that endogenous MK-7 has no inherent circadian rhythm affecting its measurement.
Human RCTReview: MK-7's higher bioavailability and longer half-life set it apart from other vitamin K forms
A review of MK-7's properties describes how, unlike vitamin K1 or MK-4, it promotes gamma-carboxylation of osteocalcin and matrix Gla protein at nutritional doses because of its superior bioavailability and longer half-life.
ReviewDose-response RCT: low-dose MK-7 improved vitamin K status with no adverse effect on blood clotting
A randomized trial in 42 healthy adults given placebo or MK-7 at 10-360mcg/day found nutritional-range doses improved carboxylation of circulating osteocalcin and matrix Gla protein, with no adverse effect observed on thrombin generation (blood clotting).
Human RCTComprehensive review of MK-7's clinical pharmacokinetics and health-related mechanisms
A synthetic review covering MK-7's molecular pathways describes its more efficient absorption relative to vitamin K1, its role converting undercarboxylated osteocalcin and matrix Gla protein to their active forms, and clinical dosing considerations.
ReviewRCT: MK-7 supplementation produced a dose- and time-dependent improvement in vitamin K-dependent proteins
A randomized trial in hemodialysis patients found daily MK-7 supplementation (45, 135, or 360mcg) produced a dose- and time-dependent decrease in circulating uncarboxylated matrix Gla protein, uncarboxylated osteocalcin, and uncarboxylated prothrombin.
Human RCTMeta-analysis of Japanese data: higher MK-7 intake correlated with better osteocalcin activation and bone density
A meta-analysis of Japanese studies found habitual intake of a natural MK-7-rich fermented food was associated with significantly elevated serum MK-7, increased carboxylated osteocalcin, decreased undercarboxylated osteocalcin, and modestly greater bone mineral density.
Meta-analysis3-year RCT: low-dose MK-7 helped decrease age-related bone loss in postmenopausal women
A 3-year randomized, placebo-controlled trial in 244 healthy postmenopausal women found daily low-dose MK-7 (180mcg) significantly improved vitamin K status and decreased the age-related decline in bone mineral density and bone strength at the lumbar spine and femoral neck.
Human RCTRCT: low-dose MK-7 (90mcg/day) reduced femoral neck bone loss in postmenopausal women
A randomized trial in 311 middle-aged and elderly adults found MK-7 supplementation at 90mcg/day significantly reduced femoral neck bone loss in postmenopausal women over 1 year, with no additional effect from co-supplementing calcium and vitamin D.
Human RCTSystematic review: vitamin K2 combined with D3 and calcium benefits bone turnover markers
A systematic review of postmenopausal women found vitamin K2 supplementation, alone or combined with vitamin D3 and calcium, improved bone mineral density and osteocalcin carboxylation markers, with the combined approach considered advantageous.
Systematic reviewMeta-analysis: vitamin K supplementation improved lumbar spine bone density and osteocalcin activation
A meta-analysis in middle-aged and older adults found vitamin K supplementation (particularly K2) increased lumbar spine bone mineral density, raised carboxylated osteocalcin, and reduced undercarboxylated osteocalcin, with a more pronounced benefit in women.
Meta-analysisAnimal study: high-dose MK-7 improved femoral mechanical strength and reduced undercarboxylated osteocalcin
A study in ovariectomized rats found high-dose MK-7 supplementation was associated with greater femoral mechanical resistance and reduced undercarboxylated osteocalcin compared with untreated controls.
Animal studyRCT: adding vitamin K to bisphosphonate therapy showed no added bone-density benefit, only a modest hip-geometry effect
A randomized, placebo-controlled trial in 105 postmenopausal women with osteoporosis and low vitamin K status found adding vitamin K to bisphosphonate, calcium and/or vitamin D treatment did not significantly change bone mineral density or bone turnover markers, though it had a modest effect on some hip geometry parameters.
Human RCTRotterdam Study: higher dietary menaquinone (K2) intake linked to lower coronary heart disease risk
A population study of 4,807 adults found that those with the highest dietary menaquinone (vitamin K2) intake had a markedly lower risk of coronary heart disease mortality and less severe aortic calcification than those with the lowest intake; dietary vitamin K1 showed no such association.
Prospective cohort studyRCT: vitamin K2 supplementation slowed arterial stiffness progression in kidney transplant recipients
A double-blind, placebo-controlled trial in vitamin K-deficient kidney transplant recipients found 12 weeks of MK-7 supplementation prevented progression of arterial stiffness (pulse wave velocity) compared with placebo, and strongly improved vitamin K status markers.
Human RCTRCT: one year of MK-7 attenuated vascular stiffness progression in post-menopausal women
A one-year randomized trial in 165 women with low vitamin K status found daily MK-7 (180mcg) significantly attenuated the progression of vascular stiffness in post-menopausal women compared with placebo, with the greatest benefit in those with high baseline stiffness.
Human RCTRCT in hemodialysis patients: vitamin K2 improved a key marker of vascular calcification inhibition, though calcification scores were unchanged
The Trevasc-HDK randomized trial in hemodialysis patients found MK-7 supplementation significantly reduced dephosphorylated-undercarboxylated matrix Gla protein - the inactive form of a vitamin K-dependent calcification inhibitor - compared with placebo over 18 months, though coronary artery calcification scores did not differ significantly between groups.
Human RCTEcological study: countries with lower dietary vitamin K2 showed higher rates of early cardiovascular death
A cross-country analysis of food-commodity data from 168 countries found populations with the lowest per-capita dietary vitamin K2 intake had roughly 2.2 times the rate of early (under age 65) cardiovascular disease death compared with populations with the highest intake, though the study was correlational, not a controlled trial.
Ecological/correlational studyPreliminary systematic review: some evidence links vitamin K status to mood, though direct MK-7 trial evidence is limited
A systematic review of 14 studies found most observational research reported an inverse association between vitamin K intake and depressive symptoms, and one small randomized trial found modest mood-score improvements with MK-7 supplementation in women with PCOS - the authors characterized the overall evidence as preliminary.
Systematic reviewRCT + animal model: vitamin K2 improved insulin-resistance-associated muscle measures
A combined animal and human study found MK-7 improved grip strength and reduced insulin resistance markers (HOMA-IR, HbA1c) in type 2 diabetes patients over 6 months of yogurt-based supplementation, alongside improved muscle mass in a high-fat-diet mouse model.
Human RCT + animal studyMeta-analysis: MK-7 supplementation showed favourable effects on some glycemic markers
A systematic review and meta-analysis of 6 randomized trials found MK-7 supplementation had desirable effects on insulin, HbA1c, and HOMA-IR, with subgroup analysis noting effects at doses of 90mcg or less over less than 12 weeks; the authors called for further high-quality research.
Meta-analysisRCT: one year of MK-7 produced a modest reduction in BMI, more pronounced in women
A one-year trial in 243 adults with low vitamin K status found MK-7 supplementation (180mcg/day) produced a small but significant reduction in BMI overall, with responders showing improved fat mass and waist-to-hip ratio, and premenopausal women showing the greatest improvements.
Human RCTAnimal toxicology study found no adverse effects from synthetic MK-7 at high oral doses
Acute and 90-day oral toxicity studies of synthetic MK-7 in mice and rats found no compound-related toxicity; the no-observed-adverse-effect level (NOAEL) was set at the highest dose tested (10mg/kg body weight/day in rats), far above typical supplemental intakes.
Animal toxicology studyStructural study explains the molecular mechanism by which warfarin blocks vitamin K recycling
A structural biology study identified how warfarin selectively binds and inhibits the vitamin K epoxide reductase enzyme that recycles vitamin K in the body - the molecular basis for why vitamin K intake and anticoagulant medications like warfarin interact.
Mechanistic studyReview of menatetrenone (MK-4) notes vitamin K2 forms differ in chemistry and therapeutic use
A review of menatetrenone (MK-4), a shorter-chain form of vitamin K2 distinct from the MK-7 used in this product, described its own bone- and cardiovascular-related research history - illustrating that different vitamin K2 forms are chemically and pharmacokinetically distinct.
ReviewFrequently asked questions
What is CanPrev K2 Drops and what does it do?
It's a liquid supplement providing 30mcg of vitamin K2 (menaquinone-7, K2VITAL®) per drop. It helps in the maintenance of bones.
How many drops do I take?
Adults 19 years and older take 4 drops per day, providing 120mcg of vitamin K2, or as directed by a health care practitioner.
What is K2VITAL®?
K2VITAL® is a branded, 100% all-trans form of menaquinone-7 (MK-7), a highly bioactive form of vitamin K2, sourced from non-soy plant oils (geraniol and farnesol).
Why is it suspended in MCT oil?
Vitamin K2 is a fat-soluble nutrient that requires a lipid carrier for absorption. This formula uses medium chain triglycerides rather than a water or powder base.
Is it suitable for people taking blood thinners?
Ask a health care practitioner prior to use if you are taking blood thinners, since vitamin K can interact with anticoagulant medication.
Is it gluten-free and allergen-friendly?
Yes - the formula is vegan, gluten-free, soy-free, dairy-free and free from artificial colours, flavours, sugar and preservatives.
How long does one bottle last?
Each 15ml bottle provides approximately 450 drops. At the adult dose of 4 drops daily, that's roughly a 112-day (about 4-month) supply.
Does it contain vitamin D3?
No - this is a K2-only formula. CanPrev also offers a separate D3 & K2 Drops product for those who want both nutrients combined.
Where do I buy it?
Use the orange button on this page - it takes you to the CanPrev listing on Amazon.ca for secure checkout and fast delivery.
Support strong bones with bioactive K2VITAL MK-7 vitamin K2
Get CanPrev K2 Drops on Amazon.ca - fast, protected delivery.
Get it on Amazon.caNatural Health Product NPN 80082329. Helps in the maintenance of bones. The research summaries below concern vitamin K2 (menaquinone-7) generally and are educational - they are not claims about this finished product. Consult a health care practitioner prior to use, especially if taking blood thinners. Read and follow the label. Results may vary.
Important information
Safety Information
Cautions and Warnings: Ask a health care practitioner prior to use if you are taking blood thinners. Keep out of reach of children. Do not use if the safety seal is broken.
Indications
Recommended Use or Purpose: Helps in the maintenance of bones.
Ingredients
Medicinal Ingredients (per drop, 0.033 mL): Vitamin K2 (menaquinone-7, K2VITAL®) 30 mcg. Non-medicinal ingredients: Medium chain triglycerides (from coconut), D-alpha tocopherol. Vegan. No gluten, dairy, soy, wheat, yeast, sugar, or artificial colours, flavours or preservatives. NMIs are subject to change - always read and follow the label for accurate ingredients, cautions and allergen information.
Directions
Recommended Dose: Adults (19 years and older): take 4 drops per day (120 mcg of vitamin K2), or as directed by a health care practitioner. Shake well before use.
Legal Disclaimer
Actual product packaging and materials may contain more and different information than shown on our website. Always read labels, warnings and directions before using or consuming a product. This item is sold and shipped by Amazon.ca; purchases are completed on Amazon.